Abstract: Synthesis of the title compound,1-(2'-O-methyl-ß-D-ribofuranosyl)-1H-imidazo- [4,5-d]pyridazine-4,7(5H,6H)-dione (1), is reported. It was synthesized in four steps, starting from methyl 1-(ß-D-ribofuranosyl)imidazo-4,5-dicarboxylate (2). The 3',5'-hydroxyl groups of 2 was protected with a bis-silylating agent to form 3, which was then methylated to form the corresponding 2'-O-methyl derivative 5. The silyl deprotection of the latter (to form 6), followed by treatment with hydrazine afforded the target nucleoside 1. The reported nucleoside has potentially beneficial applications in biomedicine based on antisense and triple-helical nucleic acid technologies.
Introduction
2'-O-Methyl oligoribonucleotides are gaining wide attention in recent years because of their newly discovered, diverse biomedical applications in viral and cancer therapies [1, 2] . Oligo-2'-O-methylribonucleotides (2'-O-methyl RNA) were recently found to strongly inhibit restriction endonuclease via formation of triple-helices with oligoribonucleotides (RNA) and genomic sequences containing the recognition site for the class II-S restriction enzyme, Ksp632-I [1] . Synthetic 2'-O-methyl-modified hammerhead ribozymes, designed to be complementary to the RNA component of human telomerase, was shown to exhibit dose-dependent inhibition of human telomerase activity in tissue culture systems with a 0.4 micromolar IC 50 value [2] . It has also been demonstrated that specific 2'-O-methyloligoribonucleotides, but not the corresponding 2'-deoxyribonucleotides, bind to E.coli tRNA (Cys), and inhibit aminoacylation of the latter by cysteine tRNA synthetase [3] . Furthermore, because of the significantly enhanced stability of their hybrids with complementary RNA as compared to that of the corresponding DNA.RNA duplexes, 2'-O-methyl-oligoribonucleotides are an attractive class of compounds for antisense-based therapeutic applications [4, 5] . We report here the synthesis of a nucleoside analogue containing a methoxy functionality at the 2'-position, namely,1-
, which can be considered an analogue of purine nucleoside in which a pyridazine moiety replaces a pyrimidine in fusion to an imidazole ring. Our molecular modeling studies suggest that nucleoside 1 has some unique structural features that would make it an attractive building block for oligonucleotides for potential antisense and triple-helical applications. These features include, but are not limited to, its potential capability to base-pair with cytidine, like guanosine, forming three H-bonds, but with a significantly shortened sugar-sugar (C-1' to C-1') distance, which in turn might lead to the decreased interstrand reach and consequently result in a somewhat compressed double-helix. The study of such an effect on the double-helical or triple-helical conformations, interactions, and stability would be interesting and rewarding.
Results and Discussion
Synthesis of the target compound commenced with methyl 1-(ß-D-ribofuranosyl)imidazole-4,5-dicarboxylate (2) [6] (Scheme I), which was selectively protected at the 3',5'-position using the Markiewicz reagent [7] 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane to form the corresponding TIPDS derivative 3 as the major product, along with a small amount of the completely silyl-protected derivative 4 [8] . Methylation of 3 with methyl iodide in the presence of silver oxide afforded the corresponding 2'-O-methyl derivative 5. The silyl deprotection of the latter with tetra-n-butylammonium fluoride gave the free nucleoside 6. The ring-closure of 6 to form the target 1 was accomplished by treatment with hydrazine. The synthesis of the parent ribofuranoside of 1, containing a 2'-OH group in place of 2'-OMe, has long been reported in the literature, both by imidazole ring-closure [6f] as well as by glycosylation of the parent heterocyclic base, imidazo [4,5-d] pyridazine-4,7(5H,6H)-dione. 
Methyl 1-[(2'-O-methyl-3',5'-O-(1,1,3,3-tetraisopropyldisiloxan-1,3-diyl))-ß-D-erythropentofuranosyl]-4,5-imidazoledicarboxylate (5).
A mixture of methyl 1- 
Methyl 1-(2'-O-methyl-ß-D-erythropentofuranosyl)-4,5-imidazoledicarboxylate (6).
A 1M solution of tetra-n-butylammonium fluoride in THF (2 mL, 2 mmol) was added to an ice-cooled solution of methyl 
